Skip to main content
Log in

Increased risk of immune thrombocytopenia following AstraZeneca Covid-19 vaccine

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Gordon SF, et al. Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia. Vaccine : 30 Oct 2021. Available from: URL: http://doi.org/10.1016/j.vaccine.2021.10.030

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Increased risk of immune thrombocytopenia following AstraZeneca Covid-19 vaccine. Reactions Weekly 1882, 9 (2021). https://doi.org/10.1007/s40278-021-05476-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-05476-5

Navigation